Inhibins and ovarian cancer

Molecular and Cellular Endocrinology

Volumn 225, Issue 1-2, 2004, Pages 65-71

  Robertson, David M ^a   Pruysers, Enid ^a   Burger, Henry G ^a   Jobling, Tom ^b   McNeilage, Jane ^b   Healy, David ^b  

^a MONASH MEDICAL CENTRE   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

Granulosa cell tumours; Inhibin subunit; Inhibin A; Inhibin B; Mucinous carcinomas; Pro C

Indexed keywords

CA 125 ANTIGEN; FOLLITROPIN; GONADOTROPIN; INHIBIN; LUTEINIZING HORMONE; TUMOR MARKER;

CANCER DIAGNOSIS; CANCER RECURRENCE; CANCER SURGERY; CONFERENCE PAPER; DIAGNOSTIC TEST; ENZYME LINKED IMMUNOSORBENT ASSAY; GERM CELL TUMOR; GRANULOSA CELL; GRANULOSA CELL TUMOR; HUMAN; IMMUNOASSAY; IMMUNOCYTOCHEMISTRY; MENOPAUSE; OVARY CANCER; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN SECRETION; PROTEIN SYNTHESIS; SENSITIVITY AND SPECIFICITY;

CA-125 ANTIGEN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INHIBINS; OVARIAN NEOPLASMS; SENSITIVITY AND SPECIFICITY;

EID: 4644249000     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2004.02.014     Document Type: Conference Paper

References (44)

1. Baird D.T., Smith K.B. Inhibin and related peptides in the regulation of reproduction. Oxford Rev. Reprod. Biol. 15:1993;191-232
2. Burger H.G., Dudley E.C., Hopper J.L., Groome N., Guthrie J.R., Green A., Dennerstein L. Prospectively measured levels of serum follicle-stimulating hormone, estradiol, and the dimeric inhibins during the menopausal transition in a population-based cohort of women. J. Clin. Endocrinol. Metab. 84:1999;4025-4030
3. Burger H.G., Fuller P.J., Chu S., Mamers P., Drummond A., Susil B., Neva P., Robertson D.M. The inhibins and ovarian cancer. Mol. Cell. Endocrinol. 180:2001;145-148
4. Choi Y.L., Kim H.S., Ahn G. Immunoexpression of inhibin alpha-subunit, inhibin/activin beta A-subunit and CD99 in ovarian tumors. Arch. Pathol. Lab. Med. 124:2000;563-569
5. Cobellis L., Cataldi P., Reis F.M., De Palo G., Raspagliesi F., Pilotti S., Arcuri F., Petralia F. Gonadal malignant germ cell tumors express immunoreactive inhibin/activin-subunits. Eur. J. Endocrinol. 145:2001;779-784
6. Cooke I., O'Brien M., Charnock F.M., Groome N., Ganesan T.S. Inhibin as a marker for ovarian cancer. Br. J. Cancer. 71:1995;1046-1050
7. Cramer, D.W., 2002. Epidemiology of sporadic ovarian cancer. In: Jacobs et al. (Eds.), Ovarian Cancer. Oxford University Press, Oxford. p. XX.
8. Fuller P.J., Chu S., Jobling T., Mamers P., Healy D.L., Burger H.G. Inhibin-subunit gene expression in ovarian cancer. Gynecol. Oncol. 73:1999;273-279
9. Fuller P.J., Chu S., Fikret S., Burger H.G. Molecular pathogenesis of granulosa cell tumours. Mol. Cell. Endocrinol. 191:2002a;89-96
10. Fuller P.J., Zumpe E.T., Chu S., Mamers P., Burger H.G. Inhibin-activin receptor-subunit gene expression in ovarian tumours. J. Clin. Endocrinol. Metab. 87:2002b;1395-1401
11. Gilfillan C.P., Robertson D.M., Burger H.G., Leoni M.A., Hurley V., Martin N.G. The control of ovulation in mothers of dizygotic twins. J. Clin. Endocrinol. Metab. 81:1996;1557-1562
12. Gurusinghe C.J., Healy D.L., Jobling T., Mamers P., Burger H.G. Inhibin and activin are demonstrable by immunohistochemistry in ovarian tumor tissue. Gynecol. Oncol. 57:1995;27-32
13. Healy D.L., Burger H.G., Mamers P., Jobling T., Bangah M., Quinn M., Grant P., Day A.J., Rome R., Campbell J.J. Elevated serum inhibin concentrations in postmenopausal women with ovarian tumours. N. Engl. J. Med. 329:1993;1539-1542
14. Holschneider C.H., Berek J.S. Ovarian cancer: epidemiology, biology, and prognostic factors. Semin. Surg. Oncol. 19:2000;3-10
15. Jaatinen T.A., Penttila T.L., Kaipia A., Ekfors T., Parvinen M., Toppari J. Expression of inhibin alpha, beta A and beta B messenger ribonucleic acids in the normal human ovary and in polycystic ovarian syndrome. J. Endocrinol. 143:1994;127-137
16. Jobling T., Mamers P., MacLachlan V., Burger H.G., Quinn M., Rome R., Day A.J. A prospective study of inhibin in granulosa cell tumors of the ovary. Gynecol. Oncol. 55:1994;285-289
17. Knight P.G. Roles of inhibins, activins, and follistatin in the female reproductive system. Front. Neuroendocrinol. 17:1996;476-509
18. Kommoss F., Oliva E., Bhan A.K., Young R.H., Scully R.E. Inhibin expression in ovarian tumors and tumor-like lesions: an immunohistochemical study. Mod. Pathol. 11:1998;656-664
19. Lambert-Messerlian G.M., Steinhoff M., Zheng W., Canick J.A., Gajewski W.H., Seifer D.D., Schneyer A. Multiple immunoreactive inhibin proteins in serum from postmenopausal women with epithelial ovarian cancer. Gynecol. Oncol. 65:1997;512-516
20. Lappohn R.E., Burger H.G., Bouma J., Bangah M., Krans M., de Bruijn H.W.A. Inhibin as a marker for granulosa cell tumours. N. Engl. J. Med. 321:1989;790-793
21. Lewis K.A., Gray P.C., Blount A.L., MacConell L.A., Wiater E., Bilezikjian L.M., Vale W. Betaglycan binds inhibin and can mediate functional antagonism of activin signalling. Nature. 404:2000;411-414
22. McLachlan R.I., Robertson D.M., Burger H.G., de Kretser D.M. The radioimmunoassay of bovine and human follicular fluid and serum inhibin. Mol. Cell. Endocrinol. 46:1986;175-185
23. Matzuk M.M., Finegold M.J., Su J.G., Hsueh A.J., Bradley A. Alpha-inhibin is a tumour-suppressor gene with gonadal specificity in mice. Nature. 360:1992;313-319
24. Matzuk M.M., Kumar T.R., Shou W., Coerver K.A., Lau A.L., Behringer R.R., Finegold M.J. Transgenic models to study the roles of inhibins and activins in reproduction, oncogenesis and development. Recent Prog. Hrmone Res. 51:1996;123-157
25. Pelkey T.J., Frierson H.F. Jr., Mills S.E., Stoler M.H. The diagnostic utility of inhibin staining in ovarian neoplasms. Int. J. Gyneciol. Pathol. 17:1998;97-105
26. Petraglia F., Luisi S., Pautier P., Sabourin J.-C., Rey R., Lhomme C., Bidart J.-M. Inhibin B is the major form of inhibin/activin family secreted by granulosa cell tumors. J. Clin. Endocrinol. Metab. 83:1998a;1029-1032
27. Phillips, D.J., 2003. The activin/inhibin family. In: Thomson, A., Lotze, M.T. (Eds.), The Cytokine Handbook, fourth ed. Academic Press, vol. 2, pp. 1153-1177.
28. Risbridger G.P., Schmitt J.F., Robertson D.M. Activin and inhibin in endocrine and other cancers. Endocr. Rev. 22:2001;836-858
29. Roberts V.J., Barth S., el-Roeiy A., Yen S.S. Expression of inhibin/activin-subunits and follistatin messenger ribonucleic acids and proteins in ovarian follicles and the corpus luteum during the human menstrual cycle. J. Clin. Endocrinol. Metab. 77:1993;1402-1410
30. Robertson D., Cahir N., Findlay J.K., Burger H.G., Groome N. The biological and immunological characterisation of inhibin A and B forms in human follicular fluid and plasma. J. Clin. Endocrinol. Metab. 82:1997;889-896
31. Robertson D.M., Cahir N., Burger H.G., Mamers P., Groome N. Inhibin forms in serum from postmenopausal women with ovarian cancers. Clin. Endocrinol. 50:1999a;381-386
32. Robertson D.M., Cahir N., Burger H.G., Mamers P., McCloud P.I., Pettersson K., McGuckin M. Combined inhibin and CA125 assays in the detection of ovarian cancer. Clin. Chem. 45:1999b;651-658
33. Robertson D.M., Stephenson T., Cahir N., Tsigos A., Pruysers E., Stanton P.G., Groome N., Thirunavukarasu P. Development of an inhibin α-subunit ELISA with broad specificity. Mol. Cell. Endocrinol. 180:2001;79-86
34. Robertson D.M., Stevenson T., Pruysers E., Burger H.G., McCloud P.I., Tsigos A., Groome N., Mamers P., McNeilage J., Jobling T., Healy D. Inhibins/activins as diagnostic markers for ovarian cancer. Mol. Cell. Endocrinol. 191:2002a;97-103
35. Robertson D.M., Stephenson T., Pruysers E., McCloud P., Tsigos A., Groome N., Mamers P., Burger H.G. Characterisation of inhibin forms and their measurement by an inhibin α-subunit ELISA in serum from postmenopausal women with ovarian cancer. J. Clin. Endocrinol. Metab. 87:2002;816-824
36. Robertson, D.M., Stephenson, T., McLachlan, R.I., 2003. Characterisation of plasma inhibin forms in fertile and infertile men. Hum. Reprod. 18, 1047-1054.
37. Staging Announcement: FIGO Cancer Committee, 1986. Gynecol. Oncol. 25, 383-385.
38. Thirunavukarasu P., Stephenson T., Forray J., Stanton P.G., Groome N., Wallace E., Robertson D.M. Changes in molecular weight forms of inhibin A and Pro-αC in maternal serum during human pregnancy. J. Clin. Endocrinol. Metab. 86:2002;5794-5804
39. Vale, W., Hseuh, A., Rivier, C., Yu, J., 1990 The inhibin/activin family of hormones and growth factors. In: Sporn M., Roberts, A. (Eds.), Peptide Growth Factors and their Receptors: Handbook of Experimental Physiology, vol. 95. Springer-Verlag, Berlin, pp. 211-248.
40. Wiater E., Vale W.W. Inhibin is an antagonist of bone morphogenetic protein signaling. J. Biol. Chem. 278:2003;7934-7941
41. Yamashita K., Yamoto M., Shikone T., Minami S., Nakano R. Immunohistochemical localization of inhibin and activin-subunits in human epithelial ovarian tumors. Am. J. Obstet. Gynecol. 180:1999;316-322
42. Zheng W., Sung C.J., Hanna I., DePetris G., Lambert-Messerlian G., Steinhoff M., Lauchlan S.C. Alpha and beta-subunits of inhibin/activin as sex cord-stromal differentiation markers. Int. J. Gynecol. Pathol. 16:1997;263-271
43. Zheng W., Lu J.J., Luo F., Zheng Y., Feng Y.-j., Felix J.C., Lauchlan S.C., Pikr M.C. Ovarian epithelial tumor growth promotion by follicle stimulating hormone and inhibition by the effect by luteinizing hormone. Gynecol. Oncol. 76:2000a;80-88
44. Zheng W., Lu J.J., Luo F., Hsieh J., Wang C.-Y., Zhang C., Chang L., Cho M.M., Stanczyk F.Z. Tumor Stroma as the main source of inhibin production in ovarian epithelial tumours. Am. J. Reprod. Immunol. 44:2000b;104-113